IL-17 receptor A antigen binding proteins
Abstract:
Disclosed is an isolated human monoclonal antibody that specifically binds IL-17 Receptor A, or an IL-17 Receptor A binding fragment thereof, and inhibits IL-17A from binding and activating the receptor. The present disclosure also provides compositions and methods for treating diseases mediated by IL-17 Receptor A activation.
Public/Granted literature
Information query
Patent Agency Ranking
0/0